The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM).
 
Max E. Scheulen
No Relationships to Disclose
 
Eckhart Kaempgen
No Relationships to Disclose
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology
 
Lucie Heinzerling
Honoraria - Amgen; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; M2D; Novartis; Roche
 
Sebastian Ochsenreither
Consulting or Advisory Role - Bristol-Myers Squibb; Glenmark; MSP; Novartis
 
Annalena Abendroth
No Relationships to Disclose
 
Ralf A. Hilger
No Relationships to Disclose
 
Matthias Grubert
No Relationships to Disclose
 
Axel Wetter
No Relationships to Disclose
 
Nika Guberina
No Relationships to Disclose
 
Sebastian Bauer
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Bayer; Blueprint Medicines; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Blueprint Genetics; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Gerold Schuler
Stock and Other Ownership Interests - Argos Therapeutics
 
Norbert Bornfeld
Consulting or Advisory Role - Allergan
Speakers' Bureau - Novartis
Research Funding - Novartis
 
Martin H. Schuler
Honoraria - Alexion Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Novartis; Roche
Research Funding - Boehringer Ingelheim; Novartis; Roche
Patents, Royalties, Other Intellectual Property - University Hospital Essen
 
Heike Richly
No Relationships to Disclose